Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients
Sahib Singh, Aakash Garg, Udaya S. Tantry, Kevin P. Bliden, Paul A. Gurbel, Martha Gulati
Topics & Concepts
MedicineInternal medicineMacePlaceboOverweightAdverse effectMyocardial infarctionDiabetes mellitusStroke (engine)Odds ratioGastroenterologyObesityEndocrinologyPercutaneous coronary interventionPathologyAlternative medicineMechanical engineeringEngineeringDiabetes Treatment and ManagementNeuroendocrine Tumor Research AdvancesNeuropeptides and Animal Physiology